Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis
Identifieur interne : 004112 ( PascalFrancis/Curation ); précédent : 004111; suivant : 004113Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis
Auteurs : Michael Walsh [Canada, Royaume-Uni] ; Fausta Catapano [Royaume-Uni] ; Wladimir Szpirt [Danemark] ; Kristian Thorlund [Canada] ; Annette Bruchfeld [Suède] ; Loic Guillevin [France] ; Marion Haubitz [Allemagne] ; Peter A. Merkel [États-Unis] ; CHEN AU PEH [Australie] ; Charles Pusey [Royaume-Uni] ; David Jayne [Royaume-Uni]Source :
- American journal of kidney diseases [ 0272-6386 ] ; 2011.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
Abstract
Background: Plasma exchange may be effective adjunctive treatment for renal vasculitis. We performed a systematic review and meta-analysis of randomized controlled trials of plasma exchange for renal vasculitis. Study Design: Systematic review and meta-analysis of articles identified from electronic databases, bibliographies, and studies identified by experts. Data were abstracted in parallel by 2 reviewers. Setting & Population: Adults with idiopathic renal vasculitis or rapidly progressive glomerulonephritis. Selection Criteria for Studies: Randomized controlled trials that compared standard care with standard care plus adjuvant plasma exchange in adult patients with either renal vasculitis or idiopathic rapidly progressive glomerulonephritis. Intervention: Adjuvant plasma exchange. Outcome: Composite of end-stage renal disease or death. Results: We identified 9 trials including 387 patients. In a fixed-effects model, the pooled RR for end-stage renal disease or death was 0.80 for patients treated with adjunctive plasma exchange compared with standard care alone (95% CI, 0.65-0.99; P = 0.04). No significant heterogeneity was detected (P = 0.5; I2 = 0%). The effect of plasma exchange did not differ significantly across the range of baseline serum creatinine values (P = 0.7) or number of plasma exchange treatments (P = 0.8). The RR for end-stage renal disease was 0.64 (95% CI, 0.47-0.88; P= 0.006), whereas the RR for death alone was 1.01 (95% CI, 0.71-1.4; P= 0.9). Limitations: Although the primary result was statistically significant, there is insufficient statistical information to reliably determine whether plasma exchange decreases the composite of end-stage renal disease or death. Conclusions: Plasma exchange may decrease the composite end point of end-stage renal disease or death in patients with renal vasculitis. Additional trials are required given the limited data available.
pA |
|
---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001E28
Links to Exploration step
Pascal:11-0199219Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis</title>
<author><name sortKey="Walsh, Michael" sort="Walsh, Michael" uniqKey="Walsh M" first="Michael" last="Walsh">Michael Walsh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Epidemiology and Biostatistics, McMaster University</s1>
<s2>Hamilton</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Catapano, Fausta" sort="Catapano, Fausta" uniqKey="Catapano F" first="Fausta" last="Catapano">Fausta Catapano</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Szpirt, Wladimir" sort="Szpirt, Wladimir" uniqKey="Szpirt W" first="Wladimir" last="Szpirt">Wladimir Szpirt</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Copenhagen University Hospital, Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
</affiliation>
</author>
<author><name sortKey="Thorlund, Kristian" sort="Thorlund, Kristian" uniqKey="Thorlund K" first="Kristian" last="Thorlund">Kristian Thorlund</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Epidemiology and Biostatistics, McMaster University</s1>
<s2>Hamilton</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Bruchfeld, Annette" sort="Bruchfeld, Annette" uniqKey="Bruchfeld A" first="Annette" last="Bruchfeld">Annette Bruchfeld</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Renal Medicine, Karolinska Institute, Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Guillevin, Loic" sort="Guillevin, Loic" uniqKey="Guillevin L" first="Loic" last="Guillevin">Loic Guillevin</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hopital Cochin, Assistance Publique, Hopitaux de Paris, Universite Paris Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haubitz, Marion" sort="Haubitz, Marion" uniqKey="Haubitz M" first="Marion" last="Haubitz">Marion Haubitz</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Department ofNephrology and Hypertension, Hannover School of Medicine</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Merkel, Peter A" sort="Merkel, Peter A" uniqKey="Merkel P" first="Peter A." last="Merkel">Peter A. Merkel</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Chen Au Peh" sort="Chen Au Peh" uniqKey="Chen Au Peh" last="Chen Au Peh">CHEN AU PEH</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Renal Unit, Royal Adelaide Hospital</s1>
<s2>Adelaide</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Pusey, Charles" sort="Pusey, Charles" uniqKey="Pusey C" first="Charles" last="Pusey">Charles Pusey</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Jayne, David" sort="Jayne, David" uniqKey="Jayne D" first="David" last="Jayne">David Jayne</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">11-0199219</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 11-0199219 INIST</idno>
<idno type="RBID">Pascal:11-0199219</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001E28</idno>
<idno type="wicri:Area/PascalFrancis/Curation">004112</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis</title>
<author><name sortKey="Walsh, Michael" sort="Walsh, Michael" uniqKey="Walsh M" first="Michael" last="Walsh">Michael Walsh</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Epidemiology and Biostatistics, McMaster University</s1>
<s2>Hamilton</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Catapano, Fausta" sort="Catapano, Fausta" uniqKey="Catapano F" first="Fausta" last="Catapano">Fausta Catapano</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Szpirt, Wladimir" sort="Szpirt, Wladimir" uniqKey="Szpirt W" first="Wladimir" last="Szpirt">Wladimir Szpirt</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Department of Nephrology, Copenhagen University Hospital, Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Danemark</country>
</affiliation>
</author>
<author><name sortKey="Thorlund, Kristian" sort="Thorlund, Kristian" uniqKey="Thorlund K" first="Kristian" last="Thorlund">Kristian Thorlund</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Clinical Epidemiology and Biostatistics, McMaster University</s1>
<s2>Hamilton</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Canada</country>
</affiliation>
</author>
<author><name sortKey="Bruchfeld, Annette" sort="Bruchfeld, Annette" uniqKey="Bruchfeld A" first="Annette" last="Bruchfeld">Annette Bruchfeld</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Renal Medicine, Karolinska Institute, Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>Suède</country>
</affiliation>
</author>
<author><name sortKey="Guillevin, Loic" sort="Guillevin, Loic" uniqKey="Guillevin L" first="Loic" last="Guillevin">Loic Guillevin</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Hopital Cochin, Assistance Publique, Hopitaux de Paris, Universite Paris Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Haubitz, Marion" sort="Haubitz, Marion" uniqKey="Haubitz M" first="Marion" last="Haubitz">Marion Haubitz</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Department ofNephrology and Hypertension, Hannover School of Medicine</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Allemagne</country>
</affiliation>
</author>
<author><name sortKey="Merkel, Peter A" sort="Merkel, Peter A" uniqKey="Merkel P" first="Peter A." last="Merkel">Peter A. Merkel</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Chen Au Peh" sort="Chen Au Peh" uniqKey="Chen Au Peh" last="Chen Au Peh">CHEN AU PEH</name>
<affiliation wicri:level="1"><inist:fA14 i1="08"><s1>Renal Unit, Royal Adelaide Hospital</s1>
<s2>Adelaide</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>Australie</country>
</affiliation>
</author>
<author><name sortKey="Pusey, Charles" sort="Pusey, Charles" uniqKey="Pusey C" first="Charles" last="Pusey">Charles Pusey</name>
<affiliation wicri:level="1"><inist:fA14 i1="09"><s1>Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Jayne, David" sort="Jayne, David" uniqKey="Jayne D" first="David" last="Jayne">David Jayne</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">American journal of kidney diseases</title>
<title level="j" type="abbreviated">Am. j. kidney dis.</title>
<idno type="ISSN">0272-6386</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">American journal of kidney diseases</title>
<title level="j" type="abbreviated">Am. j. kidney dis.</title>
<idno type="ISSN">0272-6386</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Glomerulonephritis</term>
<term>Idiopathic</term>
<term>Kidney</term>
<term>Metaanalysis</term>
<term>Nephrology</term>
<term>Plasma exchange</term>
<term>Progressive</term>
<term>Urology</term>
<term>Vasculitis</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Echange plasmatique</term>
<term>Rein</term>
<term>Vascularite</term>
<term>Idiopathique</term>
<term>Progressif</term>
<term>Néphropathie glomérulaire</term>
<term>Métaanalyse</term>
<term>Néphrologie</term>
<term>Urologie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Background: Plasma exchange may be effective adjunctive treatment for renal vasculitis. We performed a systematic review and meta-analysis of randomized controlled trials of plasma exchange for renal vasculitis. Study Design: Systematic review and meta-analysis of articles identified from electronic databases, bibliographies, and studies identified by experts. Data were abstracted in parallel by 2 reviewers. Setting & Population: Adults with idiopathic renal vasculitis or rapidly progressive glomerulonephritis. Selection Criteria for Studies: Randomized controlled trials that compared standard care with standard care plus adjuvant plasma exchange in adult patients with either renal vasculitis or idiopathic rapidly progressive glomerulonephritis. Intervention: Adjuvant plasma exchange. Outcome: Composite of end-stage renal disease or death. Results: We identified 9 trials including 387 patients. In a fixed-effects model, the pooled RR for end-stage renal disease or death was 0.80 for patients treated with adjunctive plasma exchange compared with standard care alone (95% CI, 0.65-0.99; P = 0.04). No significant heterogeneity was detected (P = 0.5; I<sup>2</sup>
= 0%). The effect of plasma exchange did not differ significantly across the range of baseline serum creatinine values (P = 0.7) or number of plasma exchange treatments (P = 0.8). The RR for end-stage renal disease was 0.64 (95% CI, 0.47-0.88; P= 0.006), whereas the RR for death alone was 1.01 (95% CI, 0.71-1.4; P= 0.9). Limitations: Although the primary result was statistically significant, there is insufficient statistical information to reliably determine whether plasma exchange decreases the composite of end-stage renal disease or death. Conclusions: Plasma exchange may decrease the composite end point of end-stage renal disease or death in patients with renal vasculitis. Additional trials are required given the limited data available.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0272-6386</s0>
</fA01>
<fA03 i2="1"><s0>Am. j. kidney dis.</s0>
</fA03>
<fA05><s2>57</s2>
</fA05>
<fA06><s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>WALSH (Michael)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CATAPANO (Fausta)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>SZPIRT (Wladimir)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>THORLUND (Kristian)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>BRUCHFELD (Annette)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>GUILLEVIN (Loic)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>HAUBITZ (Marion)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>MERKEL (Peter A.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>CHEN AU PEH</s1>
</fA11>
<fA11 i1="10" i2="1"><s1>PUSEY (Charles)</s1>
</fA11>
<fA11 i1="11" i2="1"><s1>JAYNE (David)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Clinical Epidemiology and Biostatistics, McMaster University</s1>
<s2>Hamilton</s2>
<s3>CAN</s3>
<sZ>1 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Vasculitis and Lupus Clinic, Addenbrooke's Hospital</s1>
<s2>Cambridge</s2>
<s3>GBR</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>11 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Department of Nephrology, Copenhagen University Hospital, Rigshospitalet</s1>
<s2>Copenhagen</s2>
<s3>DNK</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Renal Medicine, Karolinska Institute, Karolinska University Hospital</s1>
<s2>Stockholm</s2>
<s3>SWE</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Hopital Cochin, Assistance Publique, Hopitaux de Paris, Universite Paris Descartes</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Department ofNephrology and Hypertension, Hannover School of Medicine</s1>
<s2>Hannover</s2>
<s3>DEU</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Vasculitis Center, Section of Rheumatology, and the Clinical Epidemiology Unit, Boston University School of Medicine</s1>
<s2>Boston, MA</s2>
<s3>USA</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA14 i1="08"><s1>Renal Unit, Royal Adelaide Hospital</s1>
<s2>Adelaide</s2>
<s3>AUS</s3>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="09"><s1>Renal Section, Division of Medicine, Imperial College London, Hammersmith Hospital</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>10 aut.</sZ>
</fA14>
<fA20><s1>566-574</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>19098</s2>
<s5>354000192894050130</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>35 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>11-0199219</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>American journal of kidney diseases</s0>
</fA64>
<fA66 i1="01"><s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Background: Plasma exchange may be effective adjunctive treatment for renal vasculitis. We performed a systematic review and meta-analysis of randomized controlled trials of plasma exchange for renal vasculitis. Study Design: Systematic review and meta-analysis of articles identified from electronic databases, bibliographies, and studies identified by experts. Data were abstracted in parallel by 2 reviewers. Setting & Population: Adults with idiopathic renal vasculitis or rapidly progressive glomerulonephritis. Selection Criteria for Studies: Randomized controlled trials that compared standard care with standard care plus adjuvant plasma exchange in adult patients with either renal vasculitis or idiopathic rapidly progressive glomerulonephritis. Intervention: Adjuvant plasma exchange. Outcome: Composite of end-stage renal disease or death. Results: We identified 9 trials including 387 patients. In a fixed-effects model, the pooled RR for end-stage renal disease or death was 0.80 for patients treated with adjunctive plasma exchange compared with standard care alone (95% CI, 0.65-0.99; P = 0.04). No significant heterogeneity was detected (P = 0.5; I<sup>2</sup>
= 0%). The effect of plasma exchange did not differ significantly across the range of baseline serum creatinine values (P = 0.7) or number of plasma exchange treatments (P = 0.8). The RR for end-stage renal disease was 0.64 (95% CI, 0.47-0.88; P= 0.006), whereas the RR for death alone was 1.01 (95% CI, 0.71-1.4; P= 0.9). Limitations: Although the primary result was statistically significant, there is insufficient statistical information to reliably determine whether plasma exchange decreases the composite of end-stage renal disease or death. Conclusions: Plasma exchange may decrease the composite end point of end-stage renal disease or death in patients with renal vasculitis. Additional trials are required given the limited data available.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B14A01</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B07</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Echange plasmatique</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Plasma exchange</s0>
<s5>02</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Intercambio plasmático</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Rein</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Kidney</s0>
<s5>03</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Riñón</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Vascularite</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Vasculitis</s0>
<s5>05</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Vasculitis</s0>
<s5>05</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Idiopathique</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Idiopathic</s0>
<s5>06</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Idiopático</s0>
<s5>06</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Progressif</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Progressive</s0>
<s5>08</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Progresivo</s0>
<s5>08</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Néphropathie glomérulaire</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Glomerulonephritis</s0>
<s5>09</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Nefropatía glomerular</s0>
<s5>09</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Métaanalyse</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Metaanalysis</s0>
<s5>11</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Meta-análisis</s0>
<s5>11</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Néphrologie</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Nephrology</s0>
<s5>12</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Nefrología</s0>
<s5>12</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Urologie</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Urology</s0>
<s5>17</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Urología</s0>
<s5>17</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Appareil urinaire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Urinary system</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Aparato urinario</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Pathologie des vaisseaux sanguins</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Vascular disease</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Vaso sanguíneo patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie de l'appareil urinaire</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Urinary system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Aparato urinario patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie du rein</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Kidney disease</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Riñón patología</s0>
<s5>41</s5>
</fC07>
<fN21><s1>129</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004112 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 004112 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PascalFrancis |étape= Curation |type= RBID |clé= Pascal:11-0199219 |texte= Plasma Exchange for Renal Vasculitis and Idiopathic Rapidly Progressive Glomerulonephritis: A Meta-analysis }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |